Most conventional antitumor necrosis factor (TNF) medications have been documented to cause ILD, including infliximab, etanercept, adalimumab, golimumab, certolizumab pegol, and the IL‐6 receptor (IL‐6R) antagonist tocilizumab.34, 35, 36. The gene discussed is TNF; the disease is interstitial lung disease.